BD ANGIOCATH¿ IV CATHETER
Report
- Report Number
- 9610048-2018-00020
- Event Type
- Malfunction
- Date Received
- March 19, 2018
- Date of Event
- February 20, 2018
- Report Date
- March 23, 2018
- Manufacturer
- BECTON DICKINSON INDUSTRIAS CIRURGICAS, LTDA.
- Product Code
- FOZ
- UDI-DI
- 30382903811343
- PMA / PMN Number
- K151698
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER
Narratives
INVESTIGATION SUMMARY: FOR THE FOREIGN MATTER IN QUESTION AFTER ANALYSIS AND THE FTIR RESULTS, IT WAS POSSIBLE TO VERIFY THE PRESENCE OF ¿CELOPHANE¿ AND ¿EVA (ETHYLENE VINYL ACETHATE)¿, CONFIRMING THE CUSTOMER'S COMPLAINT. REGARDING THE INTEGRITY OF THE CATHETER TIP, THE DEFECTS CLAIMED FOR THE PRODUCT WERE NOT EVIDENCED. IN ADDITION, NO RECORDS OF RELATED NONCONFORMITIES WERE FOUND THAT COULD LEAD TO THE INCIDENT IN QUESTION. AS PER REQUEST, FTIR ANALYSIS WAS CARRIED OUT ON EACH OF THE TWO TYPES OF FM SEEN ON THE CATHETER. A SMALL PORTION OF EACH OF THE MATERIALS SEEN ON THE CATHETER WAS REMOVED FROM THE SAMPLE AND PREPARED FOR FTIR SPECTRAL ANALYSIS. THE SPECTRAL ANALYSIS SHOWS THAT THE WHITE MATERIAL ON THE CATHETER IS MOST LIKELY ETHYLENE VINYL ACETATE AND THE CLEAR STRAND OF MATERIAL ON THE CATHETER IS MOST LIKELY CELLOPHANE AND SILICONE. SAMPLES/ PHOTOS: WE RECEIVED SAMPLES OF THE CLAIMED PRODUCT AND ACCORDING TO THE ANALYSIS, IT WAS POSSIBLE TO CONFIRM THE PRESENCE FOREIGN MATTER ON THE CATHETER. DHR REVIEW: AFTER ANALYSIS OF THE RECLAIMED LOTS OF ASSEMBLED SET: 4357269, 5030022 AND 4300253 USED IN THE FINAL PRODUCT BATCH: 5036034 OF ANGIOCATH 20GA X 116IN, NO EVIDENCED AS TO THE TESTS TO VERIFY THE PRESENCE OF "FOREIGN / NO FOREIGN MATTER" AND NO RECORDS OF THIS DEFECT WERE EVIDENCED. QN/ NCMR REVIEW: THERE ARE NO RECORDS OF QUALITY NOTIFICATION (QN) OR NON-CONFORMANCE REPORT (RNC) OF FOREIGN MATTER, FOR THE LOT INVOLVED IN THIS CLAIM, ACCORDING TO THE HISTORY OF THE LOT ABOVE. INVESTIGATION CONCLUSION: CONFIRMED: FOR THE DEFECT CLAIMED FOREIGN MATTER, BD WAS ABLE TO CONFIRM/ REPRODUCE BOTH FOREIGN MATTER FOUND IN QUESTION. NOT CONFIRMED: FOR THE CLAIMED DEFECT OF CATHETER INTEGRITY, BD CANNOT CONFIRM / REPRODUCE THE INCIDENT IN QUESTION. WITH RESPECT TO THE COMPLAINT OF CELLOPHANE, THROUGH PREVIOUS INVESTIGATIONS IT CAN BE VERIFIED THAT A POSSIBLE DISSEMINATOR OF CELLOPHANE PARTICLES WAS THE FABRIC USED TO CLEAN THE ELEVATORS OF THE ANGIOCATH ASSEMBLY MACHINES, WHICH CAN LEAVE THIS KIND OF RESIDUE. THE WHITE POINT OBSERVED ON THE CATHETER, ACCORDING TO THE FTIR TESTS PERFORMED BY BD USA, RESULTED IN THE SUBSTANCE CALLED "ETHYLENE VINYL ACETATE" WHICH IS THE ADHESIVE SUBSTANCE (LACQUER) ORIGINATING FROM THE PACKAGING PAPER ITSELF. THIS ADHESIVE IS PRESENT IN THE PAPER AND IS RESPONSIBLE FOR THE ADHESIVENESS BETWEEN THE PAPER AND THE FILM AFTER THE SEALING IN THE PACKAGING MACHINE. ACTION TAKEN -"E.V.A. ETHYLENE VINYL ACETATE: CHANGE OF THE PAPER "OLIVER TOLAS WITH LACQUER " (PAPER CONTAINS ETHYLENE VINYL ACETATE) FOR ARJO / STERIMED ETHYPEL 70G / M2 PAPER (PAPER WITHOUT ETHYLENE VINYL ACETATE, NO LACQUER) WHICH INDIRECTLY CAN AVOID THIS KIND OF FOREIGN MATTER. THE ABOVE ACTIONS, AMONG OTHERS, WERE CARRIED OUT UNTIL NOVEMBER 2017, ACCORDING TO CM #084-15. THE ASSEMBLY BATCH WAS PRODUCED HAS OCCURRED IN FEBRUARY 2015." CATHETER INTEGRITY - A ROOT CAUSE FOR THIS CLAIM WAS NOT ATTRIBUTED, AS THE CLAIMED INCIDENT WAS NOT CONFIRMED.
(B)(6). A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION AND/OR DEVICE HISTORY REVIEW, A SUPPLEMENTAL REPORT WILL BE FILED.
IT WAS REPORTED THAT FOREIGN MATTER WAS ON THE CATHETER OF A BD ANGIOCATH¿ IV CATHETER. THERE WAS NO REPORT OF EXPOSURE, INJURY OR MEDICAL INTERVENTION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 194081 | BD ANGIOCATH¿ IV CATHETER | INTRAVASCULAR CATHETER | FOZ | BECTON DICKINSON INDUSTRIAS CIRURGICAS, LTDA. | 5036034 | 30382903811343 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |